ProfileGDS5678 / 1433366_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 47% 47% 46% 46% 46% 59% 45% 46% 46% 48% 46% 47% 46% 46% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.1464347
GSM967853U87-EV human glioblastoma xenograft - Control 23.0928747
GSM967854U87-EV human glioblastoma xenograft - Control 33.0949946
GSM967855U87-EV human glioblastoma xenograft - Control 43.0194246
GSM967856U87-EV human glioblastoma xenograft - Control 53.0410246
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.6501159
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.1145445
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0766746
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0645546
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.1152648
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0833946
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0709647
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0935146
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0871146